NCT06353087 Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) Status RECRUITING Phase N/A
NCT06268847 Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms Status COMPLETED Phase NA
NCT06155513 Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema Status TERMINATED Phase NA
NCT05990725 Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05938478 Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT Status RECRUITING Phase N/A
NCT05913791 Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With Eczema Status ACTIVE_NOT_RECRUITING Phase NA
NCT05873933 An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes Status WITHDRAWN Phase NA
NCT05770271 The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis Status COMPLETED Phase NA
NCT05758532 Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children Status RECRUITING Phase PHASE4
NCT05747378 Finding Patterns In Clinical Trial Experiences of Patients With Eczema Status NOT_YET_RECRUITING Phase N/A
NCT05735483 A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis Status ENROLLING_BY_INVITATION Phase PHASE3
NCT05732454 A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection Status TERMINATED Phase PHASE2/PHASE3
NCT05689151 A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis. Status RECRUITING Phase N/A
NCT05583019 Atopic Dermatitis With Accelerometry and Polysomnography (ADAP) Status COMPLETED Phase N/A
NCT05559359 A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05473325 Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) Status UNKNOWN Phase N/A